BRAVE Board Member
Mike has more than 15 years of experience in biopharma commercialization and business development on both the industry side (Actelion, NeurogesX, Acologix) and the consulting side (ZS Associates). He has experience in commercial strategy, market research, forecasting, launch planning, and reimbursement planning for a range of programs from in-line to pre-IND. He has assisted companies ranging from Fortune 100 Big Pharmas to private biotech across a wide range of therapeutic areas (including, CNS, pain (acute and neuropathic), cardiology, pulmonary hypertension, immunology, asthma/ COPD, nephrology, oncology, neurodegenerative disease, gastroenterology, osteoporosis, and
ultra-orphan). Mike has a BS from MIT and a Ph.D. in Chemistry from the University of California, Berkeley.